Diurnal secretion of growth hormone, cortisol, and dehydroepiandrosterone in pre- and perimenopausal women with active rheumatoid arthritis: a pilot case-control study
Authors:
- Marc R BlackmanMBMarc R Blackman
- Ranganath MuniyappaRMRanganath Muniyappa
- Mildred WilsonMWMildred Wilson
- Barbara E MoquinBMBarbara E Moquin
- Howard L BaldwinHBHoward L Baldwin
- Kelli A WongKWKelli A Wong
- Christopher SnyderCSChristopher Snyder
- Michael MagalnickMMMichael Magalnick
- Shaan AlliSAShaan Alli
- James ReynoldsJRJames Reynolds
- Seth M SteinbergSSSeth M Steinberg
- Raphaela Goldbach-ManskyRGRaphaela Goldbach-Mansky
Open Access
- 28 July 2007
- journal article
- research article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 9 (4) , 1-9
Abstract
Rheumatoid arthritis (RA) is associated with neuroendocrine and immunologic dysfunction leading to rheumatoid cachexia. Although excess proinflammatory cytokines can decrease somatotropic axis activity, little is known about the effects of RA on growth hormone/insulin-like growth factor-1 (GH/IGF-I) axis function. We tested the hypothesis that patients with active RA exhibit decreased GH/IGF-I axis activity. To do so, we conducted a pilot case-control study at a clinical research center in 7 pre- and perimenopausal women with active RA and 10 age- and body mass index-matched healthy women. Participants underwent blood sampling every 20 minutes for 24 hours (8 a.m. to 8 a.m.), and sera were assayed for GH, cortisol, and dehydroepiandrosterone (DHEA). Sera obtained after overnight fasting were assayed for IGF-I, IGF-binding protein (IGFBP)-1, IGFBP-3, C-reactive protein (CRP), interleukin-6 (IL-6), glucose, insulin, and lipids. Body composition and bone mineral density were evaluated by DEXA (dual emission x-ray absorptiometry) scans. In patients with RA, mean disease duration was 7.6 ± 6.8 years, and erythrocyte sedimentation rate, CRP, and IL-6 were elevated. GH half-life was shorter than in control subjects (p = 0.0037), with no other significant group differences in GH deconvolution parameters or approximate entropy scores. IGF-I (p = 0.05) and IGFBP-3 (p = 0.058) were lower, whereas IGFBP-1 tended to be higher (p = 0.066), in patients with RA, with nonsignificantly increased 24-hour total GH production rates. There were no significant group differences in cortisol or DHEA secretion. Lean body mass was lower in patients with RA (p = 0.019), particularly in the legs (p = 0.01). Women with active RA exhibit a trend toward GH insensitivity and relatively diminished diurnal cortisol and DHEA secretion for their state of inflammation. Whether these changes contribute to rheumatoid cachexia remains to be determined.Trial registration numberNCT00034060.Keywords
This publication has 45 references indexed in Scilit:
- Rheumatoid Arthritis: Neuroendocrine Immune Integrated Physiopathogenetic Perspectives and TherapyRheumatic Disease Clinics of North America, 2005
- Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventionsRheumatology, 2004
- Premature mortality in patients with rheumatoid arthritis: Evolving conceptsArthritis & Rheumatism, 2001
- Total Mortality is Increased in Rheumatoid Arthritis. A 17-Year Prospective StudyClinical Rheumatology, 2001
- Hypothalamo-pituitary-adrenal Axis and Growth Hormone Axis in Patients with Rheumatoid ArthritisScandinavian Journal of Rheumatology, 1999
- Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation.Journal of Clinical Investigation, 1997
- ANTERIOR PITUITARY FUNCTION IN PATIENTS WITH NEWLY DIAGNOSED RHEUMATOID ARTHRITISRheumatology, 1996
- Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation.Journal of Clinical Investigation, 1994
- Human Growth Hormone and Human AgingEndocrine Reviews, 1993
- [26] Deconvolution analysis of hormone data1992